New Customized Fluid Transfer Service Simplifies the Biopharmaceutical Manufacturing Process
Today’s manufacturers searching to simplify their supply chains and sharpen their production capabilities can benefit from a new fluid transfer service specifically for aseptic biopharmaceutical production.
The Thermo Scientific Customized Fluid Transfer Service provides pre-sterilized and ready-to-use consumables tailored for a customer’s facility needs, freeing up the manufacturer’s time to focus on critical operations while optimizing cleanroom usage.
Within a current good manufacturing practice (cGMP) facility, the need for a cost-effective aseptic approach to fluid transfer can place a sizable strain upon resources. Manufacturers must implement intelligent strategies to manage the complex supply chains of containers, tubing, filters and connectors — all of which need to be sterilized. This approach creates numerous operations, quality and regulatory challenges. Partnering with a single, trusted supplier to develop a customized turnkey fluid transfer solution can significantly simplify supply chain and inventory management.
“Our systems are custom built to each manufacturing facility’s needs and eliminate any on-site assembly, which not only saves time and resources, but reduces the potential for loss of sterility through human error,” said Myriam Jordan, business director, vaccines and biologics, Thermo Fisher Scientific. “By partnering with us, users can obtain a fluid transfer system that has undergone rigorous testing to meet mutually agreed upon standards, while streamlining supply chain management.”
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...